Biocompatibility evaluation of breathing gas pathways in healthcare applications - Part 1: Evaluation and testing within a risk management process (ISO 18562-1:2017)
This document specifies:
— the general principles governing the biological evaluation within a risk management process of
the gas pathways of a medical device, its parts or accessories, which are intended to provide
respiratory care or supply substances via the respiratory tract to a patient in all environments;
— the general categorization of gas pathways based on the nature and duration of their contact with
the gas stream;
— the evaluation of existing relevant data from all sources;
— the identification of gaps in the available data set on the basis of a risk analysis;
— the identification of additional data sets necessary to analyse the biological safety of the gas
pathway;
— the assessment of the biological safety of the gas pathway.
This document covers general principles regarding biocompatibility assessment of medical device
materials, which make up the gas pathway, but does not cover biological hazards arising from any
mechanical failure, unless the failure introduces a toxicity risk (e.g. by generating particulates). The
other parts of ISO 18562 cover specific tests that address potentially hazardous substances that are
added to the respirable gas stream and establish acceptance criteria for these substances.
This document addresses potential contamination of the gas stream arising from the gas pathways
within the medical device, which might then be conducted to the patient.
This document applies over the expected service life of the medical device in normal use and takes
into account the effects of any intended processing or reprocessing.
This document does not address biological evaluation of the surfaces of medical devices that are in direct
contact with the patient. The requirements for direct contact surfaces are found in the ISO 10993 series.
Medical devices, parts or accessories containing gas pathways that are addressed by this document
include, but are not limited to, ventilators, anaesthesia workstations (including gas mixers), breathing
systems, oxygen conserving equipment, oxygen concentrators, nebulizers, low-pressure hose
assemblies, humidifiers, heat and moisture exchangers, respiratory gas monitors, respiration monitors,
masks, mouth pieces, resuscitators, breathing tubes, breathing system filters and Y-pieces as well as
any breathing accessories intended to be used with such medical devices. The enclosed chamber of
an incubator, including the mattress, and the inner surface of an oxygen hood are considered to be gas
pathways and are also addressed by this document.
ΚΩΔΙΚΟΣ ΠΡΟΪΟΝΤΟΣ:
CYS EN ISO 18562-1:2020
This document specifies:
— the general principles governing the biological evaluation within a risk management process of
the gas pathways of a medical device, its parts or accessories, which are intended to provide
respiratory care or supply substances via the respiratory tract to a patient in all environments;
— the general categorization of gas pathways based on the nature and duration of their contact with
the gas stream;
— the evaluation of existing relevant data from all sources;
— the identification of gaps in the available data set on the basis of a risk analysis;
— the identification of additional data sets necessary to analyse the biological safety of the gas
pathway;
— the assessment of the biological safety of the gas pathway.
This document covers general principles regarding biocompatibility assessment of medical device
materials, which make up the gas pathway, but does not cover biological hazards arising from any
mechanical failure, unless the failure introduces a toxicity risk (e.g. by generating particulates). The
other parts of ISO 18562 cover specific tests that address potentially hazardous substances that are
added to the respirable gas stream and establish acceptance criteria for these substances.
This document addresses potential contamination of the gas stream arising from the gas pathways
within the medical device, which might then be conducted to the patient.
This document applies over the expected service life of the medical device in normal use and takes
into account the effects of any intended processing or reprocessing.
This document does not address biological evaluation of the surfaces of medical devices that are in direct
contact with the patient. The requirements for direct contact surfaces are found in the ISO 10993 series.
Medical devices, parts or accessories containing gas pathways that are addressed by this document
include, but are not limited to, ventilators, anaesthesia workstations (including gas mixers), breathing
systems, oxygen conserving equipment, oxygen concentrators, nebulizers, low-pressure hose
assemblies, humidifiers, heat and moisture exchangers, respiratory gas monitors, respiration monitors,
masks, mouth pieces, resuscitators, breathing tubes, breathing system filters and Y-pieces as well as
any breathing accessories intended to be used with such medical devices. The enclosed chamber of
an incubator, including the mattress, and the inner surface of an oxygen hood are considered to be gas
pathways and are also addressed by this document.